Q3 2024 Holdings
Filed 2024-11-14 | 54 holdings | $331.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $29.6M | 300,000 | 9.0% |
| Biohaven LTD(BHVN) | CALL | G1110E907 | $17.4M | 348,778 | 5.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $15.0M | 120,000 | 4.5% |
| Novo-Nordisk A S(NVO) | ADR | 670100205 | $13.1M | 110,000 | 4.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $13.0M | 140,000 | 3.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $12.1M | 135,000 | 3.7% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $11.5M | 350,000 | 3.5% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $10.0M | 750,000 | 3.0% |
| CG Oncology Inc(CGON) | COM | 156944100 | $9.4M | 250,000 | 2.8% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $9.2M | 800,000 | 2.8% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $9.1M | 80,000 | 2.8% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $8.9M | 140,000 | 2.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.7M | 450,000 | 2.6% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $8.6M | 190,000 | 2.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $7.8M | 52,500 | 2.4% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $7.7M | 150,000 | 2.3% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $7.6M | 150,000 | 2.3% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $7.3M | 310,000 | 2.2% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $7.2M | 1,474,995 | 2.2% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $6.8M | 375,000 | 2.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $6.5M | 128,411 | 2.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $6.4M | 535,000 | 1.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $6.1M | 215,000 | 1.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $5.5M | 75,000 | 1.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $5.2M | 195,000 | 1.6% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $4.9M | 450,000 | 1.5% |
| Corbus Pharmaceuticals Hldgs(CRBP)Put | COM NEW | 21833P301 | $4.5M | 220,000 | 1.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $4.5M | 175,000 | 1.3% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $4.3M | 2,150,000 | 1.3% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $4.1M | 78,842 | 1.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $3.8M | 650,000 | 1.2% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $3.7M | 110,000 | 1.1% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $3.7M | 50,000 | 1.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $3.6M | 100,000 | 1.1% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $3.6M | 145,000 | 1.1% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $3.3M | 160,000 | 1.0% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $3.1M | 300,000 | 0.9% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $3.1M | 1,350,000 | 0.9% |
| Savara Inc(SVRA) | COM | 805111101 | $3.1M | 725,000 | 0.9% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $2.9M | 1,500,000 | 0.9% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $2.8M | 265,000 | 0.8% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $2.6M | 500,000 | 0.8% |
| Absci Corporation(ABSI) | COM | 00091E109 | $2.1M | 550,000 | 0.6% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $2.1M | 50,000 | 0.6% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $1.9M | 125,000 | 0.6% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $1.9M | 65,000 | 0.6% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $1.9M | 85,000 | 0.6% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $1.8M | 60,000 | 0.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $1.7M | 75,000 | 0.5% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $1.6M | 887,700 | 0.5% |